[Federal Register Volume 91, Number 54 (Friday, March 20, 2026)]
[Notices]
[Pages 13607-13608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-05501]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: May 18-19, 2026.
Closed: May 18, 2026, 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Human Genome Research Institute, National
Institutes of Health, 6700 Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Meeting Format: (Hybrid).
Open: May 19, 2026, 11:00 a.m. to 5:00 p.m.
Agenda: To discuss matters of program relevance and reports of
Institute Director and Institute Staff.
Address: National Human Genome Research Institute, National
Institutes of Health, 6700 Rockledge Drive, Suite 1100, Bethesda, MD
20892.
Meeting Format: (Hybrid).
Contact Person: Issel Anne Lim, Ph.D., Deputy Director, Division
of Extramural Operations, National Human Genome Research Institute,
National Institutes of Health, 6700B Rockledge Drive, Room 3186,
Bethesda, MD 20892, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://
security.nih.gov/
[[Page 13608]]
visitors/Pages/visitor-campus-access.aspx for entrance into on-
campus and off-campus facilities. All visitor vehicles, including
taxicabs, hotel, and airport shuttles will be inspected before being
allowed on campus. Visitors attending a meeting on campus or at an
off-campus federal facility will be asked to show one form of
identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: http://www.genome.gov/council, where an agenda and any
additional information for the meeting will be posted when
available.
Bruce George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-05501 Filed 3-19-26; 8:45 am]
BILLING CODE 4140-01-P